Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc (INDV) Revenue
Annual & quarterly revenue history · segment & region breakdown
INDV · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsIndivior Pharmaceuticals Inc trailing twelve-month (TTM) revenue is $1.29B, an increase of 4.29% year-over-year from $1.24B in FY2025.
Revenue trend
2025 – 2016 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $1.24B | +$0.05B | +4.29% |
| 2024-12-31 | $1.19B | +$0.10B | +8.69% |
| 2023-12-31 | $1.09B | +$0.19B | +21.31% |
| 2022-12-31 | $0.90B | +$0.11B | +13.91% |
| 2021-12-31 | $0.79B | +$0.14B | +22.26% |
| 2020-12-31 | $0.65B | -$0.14B | -17.58% |
| 2019-12-31 | $0.79B | -$0.17B | -18.22% |
| 2018-12-31 | $0.96B | -$0.19B | -16.39% |
| 2017-12-31 | $1.15B | +$0.18B | +18.50% |
| 2016-12-31 | $0.97B | — | — |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare INDV revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Indivior Pharmaceuticals Inc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Indivior Pharmaceuticals Inc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Indivior Pharmaceuticals Inc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
INDV revenue · 4 questionsINDV's trailing twelve-month (TTM) revenue is $1.29B. That is an increase of 4.29% year-over-year from $1.24B in FY2025.
▸ Source: FMP · Indivior Pharmaceuticals Inc SEC filings · GAAP · Indivior Pharmaceuticals Inc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026